Jannine Versi
Fondatore presso My Elektra, Inc.
Patrimonio netto: 133 $ in data 31/05/2024
Profilo
Jannine C.
A Versi is the founder and currently holds the position of Chief Operating Officer at My Elektra, Inc., which was founded in 2019.
Ms. Versi also held the position of Director at DMK Pharmaceuticals Corp.
(Old).
In addition, Ms. Versi was a Director at DMK Pharmaceuticals Corp.
from 2023 to 2024.
Ms. Versi completed their undergraduate degree at the University of Pennsylvania and obtained an MBA from Harvard Business School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 06/10/2023 | 2 481 ( 0.02% ) | 74 $ | 31/05/2024 | |
| 06/10/2023 | 1 941 ( inf% ) | 58 $ | 31/05/2024 |
Posizioni attive di Jannine Versi
| Società | Posizione | Inizio |
|---|---|---|
My Elektra, Inc.
 My Elektra, Inc. Internet Software/ServicesTechnology Services My Elektra, Inc. provides women to take hormonal health journey. The company was founded in 2019 by Alessandra Henderson and Jannine Versi and is headquartered in Brooklyn, NY. | Fondatore | 01/01/2019 |
Precedenti posizioni note di Jannine Versi
| Società | Posizione | Fine |
|---|---|---|
| DMK PHARMACEUTICALS CORPORATION | Direttore/Membro del Consiglio | 27/06/2024 |
DMK Pharmaceuticals Corp. (Old)
 DMK Pharmaceuticals Corp. (Old) BiotechnologyHealth Technology DMK Pharmaceuticals Corp. (Old) was an American commercial stage neuro-biotech company that focused on developing and commercializing products for the treatment of opioid overdose and substance use disorders. The company's approved products included Zimhi® (naloxone) injection for the treatment of opioid overdose and Symjepi® (epinephrine) injection for use in the emergency treatment of acute allergic reactions, including anaphylaxis. The company was founded by Neil M. Frazer and Ebrahim Versi. DMK Pharmaceuticals Corp. was acquired by DMK Pharmaceuticals Corp. on May 25, 2023 for $27 million. | Direttore/Membro del Consiglio | - |
Formazione di Jannine Versi
| University of Pennsylvania | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| DMK PHARMACEUTICALS CORPORATION | Health Technology |
| Aziende private | 2 |
|---|---|
My Elektra, Inc.
My Elektra, Inc. Internet Software/ServicesTechnology Services My Elektra, Inc. provides women to take hormonal health journey. The company was founded in 2019 by Alessandra Henderson and Jannine Versi and is headquartered in Brooklyn, NY. | Technology Services |
DMK Pharmaceuticals Corp. (Old)
DMK Pharmaceuticals Corp. (Old) BiotechnologyHealth Technology DMK Pharmaceuticals Corp. (Old) was an American commercial stage neuro-biotech company that focused on developing and commercializing products for the treatment of opioid overdose and substance use disorders. The company's approved products included Zimhi® (naloxone) injection for the treatment of opioid overdose and Symjepi® (epinephrine) injection for use in the emergency treatment of acute allergic reactions, including anaphylaxis. The company was founded by Neil M. Frazer and Ebrahim Versi. DMK Pharmaceuticals Corp. was acquired by DMK Pharmaceuticals Corp. on May 25, 2023 for $27 million. | Health Technology |
- Borsa valori
- Insiders
- Jannine Versi
